Informação sobre produto
- (2E)-3-[2-[1-[[[2-(5-Bromo-2-pyrimidinyl)-3-cyclopentyl-1-methyl-1H-indol-6-yl]carbonyl]amino]cyclobutyl]-1-methyl-1H-benzimidazol-6-yl]-2-propenoic acid
- (E)-3-[2-[1-[[[2-(5-Bromopyrimidin-2-yl)-3-cyclopentyl-1-methyl-1H-indol-6-yl]carbonyl]amino]cyclobutyl]-1-methyl-1H-benzimidazol-6-yl]-2-propenoic acid
- BI 207127
- 2-Propenoic acid, 3-[2-[1-[[[2-(5-bromo-2-pyrimidinyl)-3-cyclopentyl-1-methyl-1H-indol-6-yl]carbonyl]amino]cyclobutyl]-1-methyl-1H-benzimidazol-6-yl]-, (2E)-
Deleobuvir is a viral inhibitor that inhibits the NS3 protease, which is an enzyme that plays a vital role in the replication of hepatitis C and HIV. Deleobuvir can be used for the treatment of lymphoproliferative disorders. Deleobuvir has been shown to inhibit the activities of enzymes involved in drug metabolism, such as CYP2B6. Deleobuvir also has a potential for drug interactions with antiretroviral drugs, such as sofosbuvir. Deleobuvir is metabolized to an active form by oxidation of the n-oxide group to form a glycosylated compound.
Propriedades químicas
Consulta técnica sobre: 3D-WYB57424 Deleobuvir
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.